Cargando…

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach

Understanding the immunological behavior of COVID-19 cases at molecular level is essential for therapeutic development. In this study, multi-omics and systems pharmacology analyses were performed to unravel the multi-targeted mechanisms of novel bioactives to combat COVID-19. Immuno-transcriptomic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthuramalingam, Pandiyan, Jeyasri, Rajendran, Valliammai, Alaguvel, Selvaraj, Anthonymuthu, Karthika, Chandrasekar, Gowrishankar, Shanmugaraj, Pandian, Shunmugiah Karutha, Ramesh, Manikandan, Chen, Jen-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410791/
https://www.ncbi.nlm.nih.gov/pubmed/32771622
http://dx.doi.org/10.1016/j.ygeno.2020.08.003
_version_ 1783568255670026240
author Muthuramalingam, Pandiyan
Jeyasri, Rajendran
Valliammai, Alaguvel
Selvaraj, Anthonymuthu
Karthika, Chandrasekar
Gowrishankar, Shanmugaraj
Pandian, Shunmugiah Karutha
Ramesh, Manikandan
Chen, Jen-Tsung
author_facet Muthuramalingam, Pandiyan
Jeyasri, Rajendran
Valliammai, Alaguvel
Selvaraj, Anthonymuthu
Karthika, Chandrasekar
Gowrishankar, Shanmugaraj
Pandian, Shunmugiah Karutha
Ramesh, Manikandan
Chen, Jen-Tsung
author_sort Muthuramalingam, Pandiyan
collection PubMed
description Understanding the immunological behavior of COVID-19 cases at molecular level is essential for therapeutic development. In this study, multi-omics and systems pharmacology analyses were performed to unravel the multi-targeted mechanisms of novel bioactives to combat COVID-19. Immuno-transcriptomic dataset of healthy controls and COVID-19 cases was retrieved from ArrayExpress. Phytocompounds from ethnobotanical plants were collected from PubChem. Differentially expressed 98 immune genes associated with COVID-19 were derived through NetworkAnalyst 3.0. Among 259 plant derived compounds, 154 compounds were targeting 13 COVID-19 immune genes involved in diverse signaling pathways. In addition, pharmacological properties of these phytocompounds were compared with COVID-19 drugs prescribed by WHO, and 25 novel phytocompounds were found to be more efficient with higher bioactive scores. The current study unravels the virogenomic signatures which can serve as therapeutic targets and identified phytocompounds with anti-COVID-19 efficacy. However, further experimental validation is essential to bring out these molecules as commercial drug candidates.
format Online
Article
Text
id pubmed-7410791
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74107912020-08-07 Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach Muthuramalingam, Pandiyan Jeyasri, Rajendran Valliammai, Alaguvel Selvaraj, Anthonymuthu Karthika, Chandrasekar Gowrishankar, Shanmugaraj Pandian, Shunmugiah Karutha Ramesh, Manikandan Chen, Jen-Tsung Genomics Article Understanding the immunological behavior of COVID-19 cases at molecular level is essential for therapeutic development. In this study, multi-omics and systems pharmacology analyses were performed to unravel the multi-targeted mechanisms of novel bioactives to combat COVID-19. Immuno-transcriptomic dataset of healthy controls and COVID-19 cases was retrieved from ArrayExpress. Phytocompounds from ethnobotanical plants were collected from PubChem. Differentially expressed 98 immune genes associated with COVID-19 were derived through NetworkAnalyst 3.0. Among 259 plant derived compounds, 154 compounds were targeting 13 COVID-19 immune genes involved in diverse signaling pathways. In addition, pharmacological properties of these phytocompounds were compared with COVID-19 drugs prescribed by WHO, and 25 novel phytocompounds were found to be more efficient with higher bioactive scores. The current study unravels the virogenomic signatures which can serve as therapeutic targets and identified phytocompounds with anti-COVID-19 efficacy. However, further experimental validation is essential to bring out these molecules as commercial drug candidates. Elsevier Inc. 2020-11 2020-08-07 /pmc/articles/PMC7410791/ /pubmed/32771622 http://dx.doi.org/10.1016/j.ygeno.2020.08.003 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Muthuramalingam, Pandiyan
Jeyasri, Rajendran
Valliammai, Alaguvel
Selvaraj, Anthonymuthu
Karthika, Chandrasekar
Gowrishankar, Shanmugaraj
Pandian, Shunmugiah Karutha
Ramesh, Manikandan
Chen, Jen-Tsung
Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach
title Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach
title_full Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach
title_fullStr Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach
title_full_unstemmed Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach
title_short Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach
title_sort global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against covid-19: an in silico approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410791/
https://www.ncbi.nlm.nih.gov/pubmed/32771622
http://dx.doi.org/10.1016/j.ygeno.2020.08.003
work_keys_str_mv AT muthuramalingampandiyan globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT jeyasrirajendran globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT valliammaialaguvel globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT selvarajanthonymuthu globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT karthikachandrasekar globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT gowrishankarshanmugaraj globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT pandianshunmugiahkarutha globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT rameshmanikandan globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach
AT chenjentsung globalmultiomicsandsystemspharmacologicalstrategyunravelthemultitargetedtherapeuticpotentialofnaturalbioactivemoleculesagainstcovid19aninsilicoapproach